ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,810Medicare Part D Prescriptions Filled, Including Refills

Rank: 64 out of 1942

$912K Total Retail Price of All Prescriptions

Rank: 5 out of 1942

326 Patients Receiving at Least One Drug in Part D
49%Patients 65 Years and Older
86% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Minnesota
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 3,707 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$84 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Minnesota
OMEPRAZOLE 627 127 1 4
LEVOTHYROXINE SODIUM 508 238 2 3
SIMVASTATIN 443 96 3 1
LISINOPRIL 315 163 4 2
TRAZODONE HCL 225 97 5 24
METOPROLOL TARTRATE 193 109 6 9
QUETIAPINE FUMARATE 192 46 7 61
RISPERIDONE 187 22 8 68
CITALOPRAM HBR 185 33 9 15
FAMOTIDINE 185 45 9 87
DIVALPROEX SODIUM 179 20 11 91
GABAPENTIN 169 51 12 16
BENZTROPINE MESYLATE 169 12 R 12 197
POLYETHYLENE GLYCOL 3350 163 65 14 28
FUROSEMIDE 158 121 15 5
ADVAIR DISKUS 155 18 16 35
HYDROCHLOROTHIAZIDE 151 101 17 8
LEVETIRACETAM 150 25 18 112
OLANZAPINE 148 26 19 94
WARFARIN SODIUM 146 122 20 11
AMLODIPINE BESYLATE 143 79 21 6
ATENOLOL 140 39 22 7
METFORMIN HCL 136 52 23 10
DETROL LA 124 12 24 116
SEROQUEL 122 24 25 146
ABILIFY 117 0 26 155
TAMSULOSIN HCL 111 43 27 29
RANITIDINE HCL 106 51 28 31
POTASSIUM CHLORIDE 105 33 29 17
VENLAFAXINE HCL ER 98 16 30 70
DESMOPRESSIN ACETATE 97 0 31 287
SERTRALINE HCL 96 74 32 20
METOPROLOL SUCCINATE 90 47 33 13
HALOPERIDOL 89 28 34 180
BACLOFEN 86 0 35 117
DONEPEZIL HCL 85 61 36 30
ZYPREXA 81 0 37 291
PROPRANOLOL HCL 80 0 38 101
TOPIRAMATE 79 0 39 183
NAMENDA 79 67 39 51
MIRTAZAPINE 71 52 41 38
CARBAMAZEPINE 69 0 42 165
OXYBUTYNIN CHLORIDE 68 15 43 99
DILTIAZEM 24HR CD 67 34 44 74
CYMBALTA 67 0 44 62
VENLAFAXINE HCL 67 21 44 182
OXYBUTYNIN CHLORIDE ER 67 22 44 118
GEMFIBROZIL 66 0 48 60
DIVALPROEX SODIUM ER 65 0 49 167
TRAMADOL HCL 63 55 50 19
FLUOXETINE HCL 63 26 50 45
FLUTICASONE PROPIONATE 58 0 52 37
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 31, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.